āagman

Not investment advice. Data and computed figures, for information only.

Rainbow Childrens Medicare Ltd

NSE: RAINBOW
₹1,248.90
+₹2.30 (+0.18%)
NSE · 16 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹12,698 Cr
CMP
₹1,248.90
52-wk High / Low
₹1,610 / 1,084
P/E
44.3
P/B
7.7
Book Value
₹162.0
Div Yield
0.28%
ROCE
17.0%
ROE
15.9%
Face Value
₹10
D/E
0.54

Price−6.2% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 15 quarters of filings. Not reported by the company.
As of 16 Oct 2026
How we compute these
Piotroski F-Score
4
/ 9
4 of 9 F-score tests passed
Graham Number
₹316
√(22.5 × EPS × book value per share)
ROIC
12.3%
vs 11.2% sector median
Cash flow to profit
1.49
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−74
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
13.9%
ROE × earnings retention ratio
ROE stability
2.6
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII −1.21DII +1.44
Latest quarter vs the previous one
Cash-accrual divergence
−5.4%
of assets
Low = accruals track cash flow
Strengths
+Annualised volatility of 23.3% is in the low band (≤25%)
+PE of 44.3x is below the sector median of 45.9x
Watch-outs
−Borrowings are up 3612.5% since FY2016 (24 to 891)
−Price trades below its 200-day moving average (0.9x)

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales287333336341330417398370353445445460470
Expenses199215218236236270264255249296298315335
Operating Profit8811811810694147134115104149147145135
OPM %30.7%35.4%35.1%31.1%28.5%35.3%33.7%31.1%29.5%33.5%33.0%31.5%28.7%
Other Income889131211131520811413
Interest15131417181818181819202021
Depreciation25272832343535343436404142
Profit before tax5685856953105947771102988784
Net Profit42636351407969575476747863
EPS (₹)4.046.206.125.023.897.776.765.555.277.417.147.595.96

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1692343214025437196509741,1741,2971,5161,7031,820
Expenses1282042663323915194856667748651,0221,1551,245
Operating Profit41305569151201165308400432494548575
OPM %24.3%12.8%17.1%17.2%27.8%28.0%25.4%31.6%34.1%33.3%32.6%32.2%31.6%
Other Income1016111081010193137514235
Interest3334424846565863778281
Depreciation91822286069738390112138151159
Profit before tax38244147589356187282295330358371
Net Profit25173136455540139212218244282290
EPS (₹)26.7418.2233.788.2510.1412.689.1014.7020.7721.3823.9727.4028.10

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital9994444444494102102102102—
Reserves1662753083073173503914989581,1571,3671,547—
Borrowings22242624476501529592570765764891—
Other Liabilities3441557389123116112140146145236—
Total Liabilities2313493994489261,0191,0811,2961,7712,1702,3772,775—
Fixed Assets781231742967027027728589311,2531,3981,756—
CWIP3531712234329623202879—
Investments7260310182258308571404—
Other Assets111194212140199265262409759590380535—
Total Assets2313493994489261,0191,0811,2961,7712,1702,3772,775—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity1526173648127170143224329321396420
Cash from Investing Activity−113−20−107−33−42−117−117−83−175−465−226−268−259
Cash from Financing Activity98−793−1−7−9−52−61−44143−102−118−147
Net Cash Flow0−131−222−147−71014

Ratios

As of 31 Mar 2026
13 periods
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—22.011.014.014.016.016.011.023.024.019.019.017.0
ROE %————————————15.9
EPS (₹)8.5626.7418.2233.788.2510.1412.689.1014.7020.7721.3823.9727.40
Book Value (₹)————————————162.0
Face Value (₹)————————————10
P/E————————————44.3
Div Yield %————————————0.28
NPM %4.114.06.89.38.78.27.56.114.017.616.315.616.2
OPM %20.024.013.017.017.028.028.025.032.034.033.033.032.0
D/E0.160.130.080.080.071.321.271.221.000.540.610.520.54
P/B————————————7.7

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+22.0%
5 years+21.0%
3 years+13.0%
TTM+18.0%
Compounded profit growth
10 years+31.0%
5 years+44.0%
3 years+6.0%
TTM+11.0%
Stock price CAGR
3 years+6.0%
Last year−7.0%
Return on equity
10 years17.0%
5 years19.0%
3 years17.0%
Last year16.0%

Shareholding pattern

As of 30 Sep 2024
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters49.83%49.83%49.83%49.85%49.84%49.84%
FIIs19.82%19.82%24.04%23.69%17.24%16.03%
DIIs15.38%15.38%14.76%15.31%21.12%22.56%
Government——————
Public14.98%14.98%11.37%11.14%11.68%11.39%
No. of shareholders75,61175,61177,15279,09288,56189,305
Change since Jun 2023 (pp)
Promoters +0.01FIIs −3.79DIIs +7.18Public −3.59

Documents

As of 11 Oct 2026
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Intimation Of Execution Of Lease Agreement With APCRDA For Development Of A Children'S Hospital At Amravati, Andhra Pradesh.Announcement under Regulation 30 (LODR)-Credit RatingClosure of Trading WindowBoard Meeting Outcome for Outcome Of Board Meeting
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingJun 2026TranscriptJun 2026PPTFeb 2026TranscriptFeb 2026PPTFeb 2026RecordingNov 2025TranscriptNov 2025PPTNov 2025RecordingAug 2025TranscriptAug 2025PPTAug 2025Recording

Corporate actions

As of 21 Jul 2026
21 Jul 2026DIVIDENDDividend - Rs 3.50 Per Share—
27 Jun 2025DIVIDENDDividend - Rs 3 Per Share—
23 Jul 2024DIVIDENDAnnual General Meeting/Dividend - Rs 3 Per Share—
22 Jun 2023DIVIDENDAnnual General Meeting/Dividend - Rs 3 Per Share—
7 Sep 2022DIVIDENDAnnual General Meeting/Dividend - Rs 2 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman